In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|
| Revenue from Operations | 290.3 | 388.6 | 408.4 | |
| Other Income | 4.8 | 8.2 | 7.9 | |
| Total Income | 295.1 | 396.8 | 416.4 | |
| Expenses | ||||
| + Cost of Materials Consumed | 178.0 | 227.8 | 233.4 | |
| + Changes in Inventories | -0.3 | 0.1 | 1.0 | |
| + Employee Benefit Expense | 19.2 | 28.1 | 31.1 | |
| + Finance Costs | 5.1 | 3.5 | 3.2 | |
| + Depreciation & Amortisation | 13.1 | 17.8 | 21.0 | |
| + Other Expenses | 30.2 | 41.1 | 42.7 | |
| Total Expenses | 245.2 | 318.4 | 332.5 | |
| EBITDA | 63.2 | 91.5 | 100.2 | |
| EBIT | 50.1 | 73.7 | 79.2 | |
| Profit | ||||
| PBT before Exceptional Items | 49.9 | 78.4 | 83.9 | |
| + Exceptional Items | -0.7 | -0.0 | -0.0 | |
| Pretax Income | 49.1 | 78.4 | 83.9 | |
| + Current Tax | 9.1 | 13.3 | 14.3 | |
| + Deferred Tax | -0.1 | 0.5 | 0.6 | |
| Tax Expense | 8.9 | 13.8 | 15.0 | |
| Net Income | 40.2 | 64.6 | 68.9 | |
| + Net Income — Continuing Ops | 40.2 | 64.6 | 68.9 | |
| + Other Comprehensive Income | 0.0 | 0.3 | 0.3 | |
| Total Comprehensive Income | 40.2 | 64.9 | 69.2 | |
| Per Share | ||||
| Basic EPS | 20.14 | 24.35 | 25.96 | |
| Diluted EPS | 20.14 | 24.35 | 25.96 | |
| Other Comprehensive Income — detail | ||||
| + Other Comprehensive Income | — | 0.3 | 0.3 | |
| + Items NOT to be Reclassified to P&L | — | 0.3 | 0.3 | |
| Per Share — as-filed variants | ||||
| Basic EPS — Continuing Operations | 20.14 | 24.35 | 25.96 | |
| Diluted EPS — Continuing Operations | 20.14 | 24.35 | 25.96 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||
| Gross Profit | 112.6 | 160.7 | 174.0 | |
| Gross Margin % | 38.78 | 41.37 | 42.60 | |
| Adjusted (ex-Exceptional Items) — derived | ||||
| Pretax Income (Adjusted, as filed) | 49.9 | 78.4 | 83.9 | |
| − Exceptional Items (reconciliation) | -0.7 | -0.0 | -0.0 | |
| Net Income Adj (tax-effected) | 40.8 | 64.6 | 68.9 | |
| EPS Adj | 20.44 | 24.36 | 25.97 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||
| Face Value | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 2.0 | 26.6 | 26.6 | |